Laverock Therapeutics logo

Laverock Therapeutics

Recent Finacing

Seed

Recent Raise

$16.4M


Laverock Therapeutics is a UK-based biotech company that develops a gene silencing platform for advanced human therapeutic applications, with a focus on regenerative medicine and immuno-oncology.

Total Funding

$16.4M

Headquarters

Stevenage, United Kingdom

Founded

2021

Focus Areas

Gene Therapy
Regenerative Medicine
Immuno-Oncology

Investors

UK Innovation & Science Seed Fund logo
Eli Lilly and Company logo
Maven Capital Partners logo
Mercia Ventures logo
Tekfen Ventures logo
Calculus Capital logo
Eos logo